INS and endothelial dysfunction: In old rats, the treatment prevented aging-induced endothelial dysfunction, oxidative stress, inflammation, and vascular insulin resistance through activation of the PI3K/Akt pathway and decreasing the response to the vasoconstrictor angiotensin II [202].